Castle Biosciences

IPO

Innovative Molecular Prognostic and Diagnostic Tests

Public · FRIENDSWOOD, United States · Founded 2007 · $50.5M raised

Headquarters
FRIENDSWOOD, Texas
Employees
501–1000
Founded
2007
Business Model
B2B
Total Funding
$50.5M
Last Round
$12.0M Series FApr 2019
Rounds
6
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Castle Biosciences is a leading diagnostics company delivering advanced molecular diagnostics and prognostic tests, including genomic profiling for melanoma and other skin cancers, to guide patient care and improve outcomes.

Summary

Castle Biosciences is a Healthcare company based in FRIENDSWOOD, United States, founded in 2007. It has raised $50.5M in total across 6 rounds, most recently a $12.0M Series F round in Apr 2019. Investors include American Cancer Society BrightEdge Fund, Industry Ventures and HealthQuest Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOJul 2019
$64.0M

Sign up to see all 7 events

Funding: Seed through Series F. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Castle Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/castle-biosciences"><img src="https://indexed.vc/api/badge/company/castle-biosciences" alt="Castle Biosciences on Indexed.vc" width="260" height="76" /></a>